Literature DB >> 27719660

Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.

Syeda Mehpara Farhat, Touqeer Ahmed1.   

Abstract

BACKGROUND: Alzheimer's disease, a neurodegenerative disorder, is characterized by accumulation of amyloid beta (Aβ) plaques, neurofibrillary tangles and loss of cholinergic neurons. LITERATURE REVIEW: The localization of Aβ plaques particularly in the cholinergic neuron-rich areas has led to the discovery that Aβ binds to α7 nicotinic acetylcholine receptors (nAChRs) with very high affinity. This discovery has led to extensive exploration of the possible outcomes of this binding, ranging from the subcellular signaling pathways to its effects on behavioral and cognitive functions. Intriguingly, there are conflicting reports about the effects of this Aβ and α7 nAChR interaction; a few studies report a neuroprotective role of this interaction while others claim that it is neurotoxic.
CONCLUSION: This review focuses on the neurotoxic and neuroprotective effects of Aβ and α7 nAChR interaction and its implications on different cell signaling pathways and other physiological functions. Moreover, the implications this interaction might have on Alzheimer's disease therapy are also discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer's disease; Aβ peptide; cholinergic; neuroprotection; neurotoxicity; α7 nicotinic receptors

Mesh:

Substances:

Year:  2017        PMID: 27719660     DOI: 10.2174/1389450117666161005145143

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  7 in total

1.  Design, synthesis, and biological activity of 5'-phenyl-1,2,5,6-tetrahydro-3,3'-bipyridine analogues as potential antagonists of nicotinic acetylcholine receptors.

Authors:  Yafei Jin; Xiaoqin Huang; Roger L Papke; Emily M Jutkiewicz; Hollis D Showalter; Chang-Guo Zhan
Journal:  Bioorg Med Chem Lett       Date:  2017-08-14       Impact factor: 2.823

2.  α7 Nicotinic Acetylcholine Receptor May Be a Pharmacological Target for Perioperative Neurocognitive Disorders.

Authors:  Penghui Wei; Wenyuan Lyu; Lin Xu; Hao Feng; Haipeng Zhou; Jianjun Li
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

3.  Activation of α7 Nicotinic Acetylcholine Receptor by its Selective Agonist Improved Learning and Memory of Amyloid Precursor Protein/Presenilin 1 (APP/PS1) Mice via the Nrf2/HO-1 Pathway.

Authors:  Kun Cao; Jie Xiang; Yang-Ting Dong; Yi Xu; Zhi-Zhong Guan
Journal:  Med Sci Monit       Date:  2022-01-04

4.  The neuroprotective effects of SIRT1 in mice carrying the APP/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670/671 may involve elevated levels of α7 nicotinic acetylcholine receptors.

Authors:  Kun Cao; Yang-Ting Dong; Jie Xiang; Yi Xu; Yi Li; Hui Song; Wen-Feng Yu; Xiao-Lan Qi; Zhi-Zhong Guan
Journal:  Aging (Albany NY)       Date:  2020-01-30       Impact factor: 5.682

Review 5.  Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease.

Authors:  Mohammad Azizur Rahman; Kamrul Islam; Saidur Rahman; Md Alamin
Journal:  Mol Neurobiol       Date:  2020-10-19       Impact factor: 5.590

6.  Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.

Authors:  Jiansong Fang; Pengyue Zhang; Quan Wang; Chien-Wei Chiang; Yadi Zhou; Yuan Hou; Jielin Xu; Rui Chen; Bin Zhang; Stephen J Lewis; James B Leverenz; Andrew A Pieper; Bingshan Li; Lang Li; Jeffrey Cummings; Feixiong Cheng
Journal:  Alzheimers Res Ther       Date:  2022-01-10       Impact factor: 8.823

Review 7.  Role of Cholinergic Signaling in Alzheimer's Disease.

Authors:  Zhi-Ru Chen; Jia-Bao Huang; Shu-Long Yang; Fen-Fang Hong
Journal:  Molecules       Date:  2022-03-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.